Assay of methylated gene RARβ2 in circulating DNA of blood from patients with lung cancer as a potential prognosticator

Voprosy Onkologii

Volumn 57, Issue 3, 2011, Pages 302-307

  Ponomaryova, A A ^a   Rykova, Ye Yu ^b   Cherdyntseva, N V ^a   Skvortsova, T E ^b   Dobrodeev, A Yu ^a   Litvyakov, N V ^a   Zavyalov, A A ^a,c   Tuzikov, S A ^a,c   Vlassov, V V ^b   Laktionov, P P ^b  

^a CANCER RESEARCH INSTITUTE   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^c OMSK STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RAR BETA2 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; GENETIC ANALYSIS; HUMAN; LUNG NON SMALL CELL CANCER; PROGNOSIS;

ADULT; CARCINOMA, NON-SMALL-CELL LUNG; DNA, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METHYLATION; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; RISK FACTORS;

EID: 80052233750     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diehl F., Schmidt K., Choti M.A. et al. Circulating mutant DNA to assess tumor dynamics // Nat. Med. - 2008. - Vol. 14. - P. 985-990.
2. Elistratova E.V., Shelestyuk P.I., Permyakova V.I. et al. Blood-based methylated DNA and tumor-specific protein analysis in gastric cancer diagnostics // Circulating Nucleic Acids in Plasma and Serum / P.B.Gahan, ed. - United Kindom: Springer, 2011. - P. 57-62.
3. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism // Ann. Rev. Pharmacol. Toxicol. - 2005. - Vol. 45. - P. 629-656.
4. Fackler M.J., McVeigh M., Mehrotra J. et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer // Cancer Res. - 2004. - Vol. 64. - P. 4442-4452.
5. Fleischhacker M., Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey // Biochim. Biophys. Acta. - 2007. - Vol. 1775. - P. 181-232.
6. Fujiwara K., Fujimoto N., Tabata M. et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer // Clin. Cancer Res. - 2005. - Vol. 11. - P. 1219-1225.
7. Hsu H.S., Chen T.P., Hung C.H. et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma // Cancer (Philad.). - 2007. - Vol. 110. - P. 2019-2026.
8. Jahr S., Hentze H., Englisch S. et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cell // Cancer Res. - 2001. - Vol. 61. - P. 1659-1665.
9. Kolesnikova E.V., Tamkovich S.N., Bryzgunova O.E. et al Circulating DNA in the blood of gastric cancer patients // Ann. NY Acad. Sci. - 2008. - Vol. 1137. - P. 226-231.
10. Korshunova Y., Maloney R.K., Lakey N. et al. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA // Genome Res. - 2008. - Vol. 18. - P. 19-29.
11. Laktionov P.P., Tamkovich S.N., Rykova E.Y. et al. Extracellular circulating nucleic acids in human plasma in health and disease // Nucleosides Nucleotides Nucleic Acids. - 2004. - Vol. 23. - P. 879-883.
12. Kumar S., Guleria R., Singh V. et al. Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer // Europ. Respir J. - 2010. - Vol. 36. - P. 885-892.
13. Lee E-S., Issa J-P., Roberts D.B. et al. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific per technique and clinical significance // Clin. Cancer Res. - 2008. - Vol. 14. - P. 2664-2672.
14. Lehmann U., Länger F., Feist H. et al. Quantitative assessment of promoter hypermethylation during breast cancer development // Amer. J. Pathol. - 2002. - Vol. 160. - P. 605-612.
15. Olaussen K.A., Dunant A., Fouret P. et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy // New Engl. J. Med. - 2006. - Vol. 355. - P. 983-991.
16. Ponomaryova A.A., Rykova E.Y., Cherdyntseva N.V. et al. Concentration and distribution of single-copy β-actin gene and LINE-1 repetitive elements in blood of lung cancer patients // Circulating Nucleic Acids in Plasma and Serum / P.B.Gahan, ed. - United Kindom: Springer, 2011. - P. 41-45.
17. Rykova E.Y., Skvortsova T.E., Laktionov P.P. et al. Investigation of tumor-derived extracellular DNA in blood of cancer patients by methylation-specific PCR // Nucleosides, nucleotides Nucleic Acids. - 2004. - Vol. 23. - P. 855-859.
18. Sirera R., Bremnes R.M., Cabrera A. et al. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer // J. Thorac. Oncol. - 2011. - Vol. 6. - P. 286-290.
19. Skvortsova T.E., Vlassov V.V., Laktionov P.P. Binding and penetration of methylated DNA into primary and transformed human cells // Ann. NY Acad. Sci. - 2008. - Vol. 1137. - P. 36-40.
20. Skvortsova T.E., Bryzgunova O.E., Lebedeva A.O. et al. Methylated cell-free DNA in vitro and in vivo // Circulating Nucleic Acids in Plasma and Serum / P.B.Gahan, ed. - United Kindom: Springer, 2011. - P. 185-194.
21. Tamkovich S.N., Bryzgunova O.E., Rykova E.Y. et al. Circulating nucleic acids in blood of healthy male and female donors // Clin. Chem. - 2005. - Vol. 51. - P. 1317-1319.
22. van der Drift M.A., Hol B.E., Klaassen C.H. et al. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer // Lung Cancer. - 2010. - Vol. 68. - P. 283-287.
23. Vlassov V.V., Laktionov P.P., Rykova E.Y. Circulating nucleic acids as a potential source for cancer biomarkers // Curr. Mol. Med. - 2010. - Vol. 10. - P. 142-165.